Pacific Biosciences of California Inc (STU:P09)
€ 2.319 0.068 (3.02%) Market Cap: 639.11 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 57/100

Q3 2023 Pacific Biosciences of California Inc Earnings Call Transcript

Oct 30, 2023 / 08:30PM GMT
Release Date Price: €6.46 (-3.37%)
Operator

Good afternoon, everyone, and welcome to the PacBio Third Quarter 2023 Earnings Conference Call. (Operator Instructions) Please also note today's event is being recorded. At this time, I'd like to turn the floor over to Todd Friedman, Senior Director of Investor Relations. Sir, please go ahead.

Todd Friedman

Thank you, Jamie. Good afternoon, and welcome to PacBio's third quarter 2023 earnings conference call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or is furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. With me today are Christian Henry, President and Chief Executive Officer; and Susan Kim, Chief Financial Officer.

On today's call, we will be making forward-looking statements, including statements regarding predictions, progress, estimates

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot